HJRES 58119th CongressIn Committee

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".

Introduced: Feb 12, 2025

Standard Summary

Comprehensive overview in 1-2 paragraphs

This joint resolution uses the Congressional Review Act to disapprove a Centers for Medicare & Medicaid Services (CMS) rule related to Medicare Home Health for calendar year 2025. If enacted, the rule titled “Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies” would have no force or effect. In short, Congress would block CMS’s proposed changes to home health payment rates, quality reporting requirements, value-based purchasing, IVIG reimbursement, and other related Medicare policies for CY 2025.

Key Points

1The bill is a joint resolution under the Congressional Review Act, introduced in the House and referred to Ways and Means and Energy and Commerce.
2It disapproves CMS’s rule published in the Federal Register on November 7, 2024 (89 Fed. Reg. 88354), covering CY 2025 HH PPS rate updates, quality reporting requirements, value-based purchasing expanded model requirements, IVIG rate updates, and other Medicare policies.
3If enacted, the rule would have no force or effect, meaning CMS would not implement the CY 2025 changes described in the rule.
4The underlying effect is a rejection of the proposed changes to home health payment rates and related programs for CY 2025, returning the program to the status quo prior to that rule (subject to any other legal constraints and prior policy).
5The sponsor listed is Mr. Clyde; the bill’s status is “Introduced,” with referral to the committees noted above.

Impact Areas

Primary: Home health agencies and providers that bill Medicare for CY 2025 services; Medicare beneficiaries who rely on home health care; entities affected by HH PPS payment rates, quality reporting, and value-based purchasing requirements.Secondary: Suppliers and vendors related to Home IVIG items and services; organizations involved in HH quality reporting and data collection; healthcare payers and downstream beneficiaries affected by changes in Medicare policy and payment behavior.Additional impacts: Potential effects on Medicare program costs and budgeting for CY 2025; potential shifts in provider incentives and service delivery intensity if the CMS proposed changes were blocked and prior policies remained in place.The rule targeted by this resolution includes multiple components: the CY 2025 HH PPS rate update, HH Quality Reporting Program requirements, HH Value-Based Purchasing Expanded Model requirements, IVIG items and services rate update, and other miscellaneous Medicare policies. Blocking the rule means those CY 2025 changes would not take effect.Under the Congressional Review Act, disapproval typically means the rule has no legal effect as written. A separate CMS rule addressing the same subject could still be proposed, but would again be subject to separate CRA review.

Generated by gpt-5-nano on Nov 18, 2025